A Phase II Single-centered Randomized Controlled Trials of Concurrent Chemoradiotherapy with S-1 Plus Cisplatin Compared to 5-fluorouracil Plus Cisplatin in Non-operable Esophageal Carcinoma.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 08 Nov 2016

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Fluorouracil (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Cisplatin
Indications Oesophageal cancer
Focus Therapeutic Use
Sponsors Shandong New age Pharmaceutical

19 Jul 2015 Status changed from not yet recruiting to completed.
21 May 2012 Planned end date changed from 1 Oct 2013 to 31 Oct 2016 as reported by Chinese Clinical Trial Register.
05 Sep 2011 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com